Christopher Causey is of UNITED THERAPEUTICS Corp. Currently has a direct ownership of 3,675 shares of UTHR, which is worth approximately $1.34 Million. The most recent transaction as insider was on Jun 27, 2022, when has been sold 5,000 shares (Common Stock) at a price of $76.36 per share, resulting in proceeds of $381,800. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.68K
12.19% 3M change
12.19% 12M change
Total Value Held $1.34 Million

CHRISTOPHER CAUSEY Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 27 2022
BUY
Exercise of conversion of derivative security
$381,800 $76.36 p/Share
5,000 Added 46.84%
5,675 Common Stock
May 27 2022
SELL
Bona fide gift
-
75 Reduced 10.0%
675 Common Stock
May 26 2022
SELL
Open market or private sale
$1,124,100 $224.82 p/Share
5,000 Reduced 86.96%
750 Common Stock
May 26 2022
BUY
Exercise of conversion of derivative security
$381,800 $76.36 p/Share
5,000 Added 46.51%
5,750 Common Stock
Aug 06 2021
SELL
Open market or private sale
$548,100 $210.0 p/Share
2,610 Reduced 77.68%
750 Common Stock
Aug 06 2021
BUY
Exercise of conversion of derivative security
$199,300 $76.36 p/Share
2,610 Added 43.72%
3,360 Common Stock
May 26 2021
SELL
Bona fide gift
-
75 Reduced 9.09%
750 Common Stock
Jan 15 2021
SELL
Sale (or disposition) back to the issuer
$259,230 $172.82 p/Share
1,500 Reduced 64.52%
825 Common Stock
Jan 15 2021
BUY
Exercise of conversion of derivative security
$132,045 $88.03 p/Share
1,500 Added 39.22%
2,325 Common Stock
Jan 07 2021
SELL
Sale (or disposition) back to the issuer
$250,575 $167.05 p/Share
1,500 Reduced 64.52%
825 Common Stock
Jan 07 2021
BUY
Exercise of conversion of derivative security
$132,045 $88.03 p/Share
1,500 Added 39.22%
2,325 Common Stock
Jan 06 2021
SELL
Sale (or disposition) back to the issuer
$245,265 $163.51 p/Share
1,500 Reduced 64.52%
825 Common Stock
Jan 06 2021
BUY
Exercise of conversion of derivative security
$132,045 $88.03 p/Share
1,500 Added 39.22%
2,325 Common Stock
Jan 05 2021
SELL
Sale (or disposition) back to the issuer
$235,155 $156.77 p/Share
1,500 Reduced 64.52%
825 Common Stock
Jan 05 2021
BUY
Exercise of conversion of derivative security
$132,045 $88.03 p/Share
1,500 Added 39.22%
2,325 Common Stock
Dec 31 2020
SELL
Sale (or disposition) back to the issuer
$1,138,425 $151.79 p/Share
7,500 Reduced 90.09%
825 Common Stock
Dec 31 2020
BUY
Exercise of conversion of derivative security
$660,225 $88.03 p/Share
7,500 Added 47.39%
8,325 Common Stock
Dec 23 2020
SELL
Sale (or disposition) back to the issuer
$224,040 $149.36 p/Share
1,500 Reduced 64.52%
825 Common Stock
Dec 23 2020
BUY
Exercise of conversion of derivative security
$132,045 $88.03 p/Share
1,500 Added 39.22%
2,325 Common Stock
Oct 28 2020
SELL
Sale (or disposition) back to the issuer
$264,060 $132.03 p/Share
2,000 Reduced 70.8%
825 Common Stock
Oct 28 2020
BUY
Exercise of conversion of derivative security
$127,800 $63.9 p/Share
2,000 Added 41.45%
2,825 Common Stock
Oct 22 2020
SELL
Sale (or disposition) back to the issuer
$305,250 $122.1 p/Share
2,500 Reduced 75.19%
825 Common Stock
Oct 22 2020
BUY
Exercise of conversion of derivative security
$159,750 $63.9 p/Share
2,500 Added 42.92%
3,325 Common Stock
Oct 16 2020
SELL
Sale (or disposition) back to the issuer
$258,750 $115.0 p/Share
2,250 Reduced 73.17%
825 Common Stock
Oct 16 2020
BUY
Exercise of conversion of derivative security
$143,775 $63.9 p/Share
2,250 Added 49.18%
2,325 Common Stock
CC

Christopher Causey

Silver Spring, MD

Track Institutional and Insider Activities on UTHR

Follow UNITED THERAPEUTICS Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells UTHR shares.

Notify only if

Insider Trading

Get notified when an United Therapeutics Corp insider buys or sells UTHR shares.

Notify only if

News

Receive news related to UNITED THERAPEUTICS Corp

Track Activities on UTHR